{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:30:17Z","timestamp":1790998217709,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ygyno.2021.06.022","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T03:42:34Z","timestamp":1625110954000},"page":"707-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk of cardiovascular disease among women carrying BRCA mutations after risk-reducing bilateral salpingo-oophorectomy: A population-based study"],"prefix":"10.1016","volume":"162","author":[{"given":"Helena Abreu","family":"do Valle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona","family":"Cheifetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesa","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian E.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.06.022_bb0005","series-title":"Estimated cancer incidence, and mortality and prevalence worldwide in 2020","author":"GLOBOCAN","year":"2020"},{"issue":"3","key":"10.1016\/j.ygyno.2021.06.022_bb0010","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1097\/AOG.0000000000002296","article-title":"Hereditary breast and ovarian cancer syndrome","volume":"130","author":"Practice Bulletin No 182","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.06.022_bb0015","article-title":"Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations","volume":"8","author":"Eleje","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.ygyno.2021.06.022_bb0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2021.06.022_bb0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2018.12.014","article-title":"Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits","volume":"153","author":"Gordhandas","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.06.022_bb0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.mcna.2015.01.006","article-title":"Menopause","volume":"99","author":"Takahashi","year":"2015","journal-title":"Med. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.ygyno.2021.06.022_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses\u2019 health study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.06.022_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause."},{"issue":"8","key":"10.1016\/j.ygyno.2021.06.022_bb0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/00016349509013475","article-title":"Risks of perimenopausal fractures-a prospective population-based study","volume":"74","author":"Tuppurainen","year":"1995","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"8","key":"10.1016\/j.ygyno.2021.06.022_bb0050","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/humrep\/deaa124","article-title":"Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies","volume":"35","author":"Zhu","year":"2020","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ygyno.2021.06.022_bb0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bpobgyn.2020.01.006","article-title":"Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers","volume":"65","author":"Gaba","year":"2020","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2021.06.022_bb0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.maturitas.2016.06.012","article-title":"Cardiovascular risk of BRCA1\/2 mutation carriers: a review","volume":"91","author":"van Westerop","year":"2016","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.ygyno.2021.06.022_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2014.01.008","article-title":"BRCA1\/2 mutation carriers are potentially at higher cardiovascular risk","volume":"91","author":"Arts-de Jong","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2021.06.022_bb0070","author":"Canadian Institute for Health Information"},{"key":"10.1016\/j.ygyno.2021.06.022_bb0075","author":"British Columbia Ministry of Health"},{"key":"10.1016\/j.ygyno.2021.06.022_bb0080","author":"BC Cancer Agency Registry Data"},{"key":"10.1016\/j.ygyno.2021.06.022_bb0085","author":"BC Vital Statistics Agency"},{"key":"10.1016\/j.ygyno.2021.06.022_bb0090","author":"British Columbia Ministry of Health"},{"issue":"2","key":"10.1016\/j.ygyno.2021.06.022_bb0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/clc.22886","article-title":"The connection between the breast and heart in a woman: breast cancer and cardiovascular disease","volume":"41","author":"Gulati","year":"2018","journal-title":"Clin. Cardiol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.06.022_bb0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10549-017-4282-9","article-title":"Risk of death from cardiovascular disease following breast cancer: a systematic review","volume":"164","author":"Gernaat","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.ygyno.2021.06.022_bb0105","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/GME.0000000000001348","article-title":"High risk for cardiovascular disease in postmenopausal breast cancer survivors","volume":"26","author":"de Buttros","year":"2019","journal-title":"Menopause."},{"issue":"9407","key":"10.1016\/j.ygyno.2021.06.022_bb0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.ygyno.2021.06.022_bb0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2012.07.003","article-title":"Hormone replacement therapy after breast cancer: 10 year follow up of the stockholm randomised trial","volume":"49","author":"Fahl\u00e9n","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2021.06.022_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2012.12.064","article-title":"BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis","volume":"146","author":"Singh","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.ygyno.2021.06.022_bb0125","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jtcvs.2012.12.046","article-title":"Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1","volume":"146","author":"Singh","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.ygyno.2021.06.022_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1601","article-title":"BRCA1 is an essential regulator of heart function and survival following myocardial infarction","volume":"2","author":"Shukla","year":"2011","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.ygyno.2021.06.022_bb0135","article-title":"BReast CAncer susceptibility gene 2 deficiency exacerbates oxidized LDL-induced DNA damage and endothelial apoptosis","volume":"8","author":"Singh","year":"2020","journal-title":"Phys. Rep."},{"issue":"22","key":"10.1016\/j.ygyno.2021.06.022_bb0140","doi-asserted-by":"crossref","first-page":"15931","DOI":"10.18632\/oncotarget.24638","article-title":"Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?","volume":"9","author":"Ben-Aharon","year":"2018","journal-title":"Oncotarget."},{"issue":"6","key":"10.1016\/j.ygyno.2021.06.022_bb0145","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.fertnstert.2013.01.109","article-title":"Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation","volume":"99","author":"Finch","year":"2013","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.ygyno.2021.06.022_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10689-011-9480-8","article-title":"Non-cancer endpoints in BRCA1\/2 carriers after risk-reducing salpingo-oophorectomy","volume":"11","author":"Cohen","year":"2012","journal-title":"Familial Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.06.022_bb0155","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ygyno.2018.10.010","article-title":"Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations","volume":"151","author":"Powell","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.06.022_bb0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/IGC.0b013e3181ca5ff4","article-title":"Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer","volume":"20","author":"Michelsen","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"82\u2013003\u2013X","key":"10.1016\/j.ygyno.2021.06.022_bb0165","first-page":"3","article-title":"Socioeconomic disparities in life and health expectancy among the household population in Canada","volume":"31","author":"Bushnik","year":"2020","journal-title":"Stat. Canada"},{"issue":"11","key":"10.1016\/j.ygyno.2021.06.022_bb0170","first-page":"e563","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.ygyno.2021.06.022_bb0175","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"3","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.ygyno.2021.06.022_bb0180","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jacc.2005.10.076","article-title":"Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions","volume":"47","author":"Ouyang","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.ygyno.2021.06.022_bb0185","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2021.06.022_bb0190","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3747\/co.26.4068","article-title":"Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia","volume":"26","author":"Hanley","year":"2019","journal-title":"Curr. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2021.06.022_bb0195","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1471-0528.2005.00696.x","article-title":"The association of hysterectomy and menopause: a prospective cohort study","volume":"112","author":"Farquhar","year":"2005","journal-title":"BJOG."},{"issue":"2","key":"10.1016\/j.ygyno.2021.06.022_bb0200","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2020.02.005","article-title":"Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada","volume":"223","author":"Hanley","year":"2020","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:57:22Z","timestamp":1758772642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821005205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0090825821005205"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.022","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of cardiovascular disease among women carrying BRCA mutations after risk-reducing bilateral salpingo-oophorectomy: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}